Loading clinical trials...
Loading clinical trials...
Selective Modulation of Cognitive, Affective, and Motor Function by Transcranial Direct Current Stimulation as Co-adjuvant Therapy in Parkinson's Disease.
The purpose of this research is to determine whether repetitive sessions of transcranial direct current stimulation (tDCS) to the prefrontal cortex can enhance the cognitive, affective and motor functioning of those with Parkinson's Disease. In this study we will compare active tDCS with sham tDCS. Each subject will receive two consecutive weeks of stimulation (Monday through Friday). A battery of neuropsychological and affective tests will be administered throughout the duration of the study.
Note that this study is a two-center study (the other center is Beth Israel Deaconess Medical Center - PI - Alvaro Pascual-Leone) \* Further study details are provided by Spaulding Rehabilitation Hospital.
Age
40 - 90 years
Sex
ALL
Healthy Volunteers
Yes
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States
Berenson Allen Center for Noninvasive Brain Stimulation
Boston, Massachusetts, United States
Start Date
December 1, 2009
Primary Completion Date
March 1, 2013
Completion Date
March 1, 2013
Last Updated
April 24, 2020
12
ACTUAL participants
Transcranial direct current stimulation
DEVICE
Lead Sponsor
Spaulding Rehabilitation Hospital
NCT07310264
NCT02119611
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07216976